Skip to main content
. Author manuscript; available in PMC: 2023 Jan 1.
Published in final edited form as: Biol Psychiatry Cogn Neurosci Neuroimaging. 2020 May 6;7(1):108–118. doi: 10.1016/j.bpsc.2020.04.014

Table 1.

Demographics, clinical measures, and covariates1

Data Set 1
FEP (n = 55) HC (n = 41) t 2 p value
Gender (%male) 65.4 65.8 0.002 .968
Age 24.18 (6.27) 24.73 (6.29) 0.425 .672
Socioeconomic status2 5.80 (4.83)3 4.12 (4.03) 12.349 .499
Smoking (packs per day) 0.23 (0.34)4 0.03 (0.10)4 −4.020 < .001
BPRS Total 51.64 (11.89)
    Positive 11.78 (3.47)
    Negative 6.20 (3.36)
RBANS5 Total 75.67 (15.04) 94.83 (11.14) 6.368 < .001
    Immediate Memory 83.02 (18.37) 102.11 (16.17) 4.914 < .001
    Visuospatial/Constructional 76.40 (17.20) 84.94 (13.85) 2.421 .018
    Language 83.73 (16.21) 99.46 (15.17) 4.483 < .001
    Attention 81.56 (16.38) 102.57 (17.49) 5.608 < .001
    Delayed Memory 79.69 (13.26) 93.11 (9.28) 5.139 < .001
Resting state fMRI
    % of volumes retained after scrubbing 93.77 (6.97) 97.32 (3.63) −3.232 .002
    Framewise displacement (mm) 0.32 (0.19) 0.22 (0.10) −3.279 .002
MRS6
    Glx 10.87 (2.56) 10.19 (1.42) −1.492 .140
    NAA 15.61 (1.19) 15.91 (1.50) 1.003 .319
    Signal to noise ratio 9.40 (1.70) 9.73 (1.52) 0.923 .359
    Full width at half maximum 0.06 (0.01) 0.06 (0.00) −1.787 .078
    Glx Cramér–Rao lower bound 14.41 (4.37) 13.92 (3.84) −0.523 .602
    NAA Cramér–Rao lower bound 1.96 (0.58) 2.00 (0.38) 1.003 .319
    Voxel gray matter content 60.21 (4.04) 59.43 (4.79) −0.790 .432
    Voxel white matter content 35.25 (5.05) 36.01 (5.65) 0.635 .527
Data Set 2
SZ (n = 42) HC (n = 41) t 2 p value
Gender (%male) 71.4 75.6 .186 .666
Age 27.64 (9.61) 28.73 (9.37) .522 .603
Socioeconomic status2 6.62 (5.81)3 5.27 (4.23) −15.790 .261
Smoking (packs per day) 0.32 (0.48) 0.26 (0.47) −.534 .595
APD naïve (yes/ no) 27/15
BPRS Total 49.67 (9.18)
    Positive 9.74 (3.49)
    Negative 7.52 (9.18)
RBANS5 Total 70.70 (14.87) 91.61 (13.20) 6.697 < .001
    Immediate Memory 77.90 (17.06) 97.39 (14.33) 5.573 < .001
    Visuospatial/Constructional 70.28 (15.81) 84.37 (17.73) 3.772 < .001
    Language 83.65 (11.67) 98.78 (15.10) 5.038 < .001
    Attention 77.10 (21.91) 95.80 (18.51) 4.155 < .001
    Delayed Memory 73.83 (20.22) 92.71 (9.30) 5.378 < .001
Resting state fMRI
    % of volumes retained after scrubbing 93.11 (7.64) 96.96 (3.81) −2.919 .005
    Framewise displacement (mm) 0.29 (0.14) 0.36 (.19) −1.949 .055

Abbreviations: FEP first episode psychosis patients; SZ patients with schizophrenia; HC healthy controls; APD antipsychotic drug; NAA N-acetylaspartate; BPRS Brief Psychiatric Rating Scale (positive subscale included conceptual disorganization, hallucinatory behavior, and unusual thought content; negative subscale included emotional withdrawal, motor retardation, and blunted affect); RBANS Repeatable Battery for the Assessment of Neuropsychological Status; MRS magnetic resonance spectroscopy; Glx glutamate + glutamine; NAA N-acetylaspartate; fMRI functional magnetic resonance imaging.

1

Mean (standard deviation) unless indicated otherwise.

2

Parental socioeconomic ranks determined from Diagnostic Interview for Genetic Studies (1–18 scale); higher rank (lower numerical value) corresponds to higher socioeconomic status.

3

Data Set 1: Data not available for 10 FEP subjects; n=45; Data Set 2: Data not available for 2 SZ subjects; n=39

4

Data Set 1: Data not available for 4 FEP subjects or 2 HC; FEP n=51, HC n = 39.

5

Data Set 1: Data not available for 7 FEP subjects or 6 HC; FEP n=48, HC n = 35; Data Set 2: Data not available for 1 SZ subject; SZ n=40.

6

Data not available for 12 FEP subjects or 4 HC; FEP n=43, HC n = 37